Folate metabolism abnormalities in autism: potential biomarkers. (August 2017)

• Record Type: Journal Article
• Authors: Frye, Richard E; Slattery, John C; Quadros, Edward V
• Is Part Of: Biomarkers in medicine. Volume 11:Number 8(2017)
• Page Start: 687
• Page End: 699
• Publication Date: 2017-08
• Subjects: autism spectrum disorder -- cerebral folate deficiency -- folate -- folate receptor α autoantibodies -- folinic acid -- genetic–environmental interactions -- methylation -- microbiome -- mitochondria -- prenatal folate supplementation; Biochemical markers -- Periodicals; 610.28
• DOI: 10.2217/bmm-2017-0109
• Languages: English
• ISSNs: 1752-0363

Abstract

Autism spectrum disorder (ASD) has been linked to abnormalities in folate metabolism. Polymorphisms in folate genes may act in complex polygenic ways to increase the risk of developing ASD. Autoantibodies that block folate transport into the brain have been associated with ASD and children with ASD and these autoantibodies respond to high doses of a reduced form of folate known as folinic acid (leucovorin calcium). Some of the same abnormalities are also found in mothers of children with ASD and supplementing folate during preconception and gestational periods reduces the risk to the offspring from developing ASD. These data suggest that folate pathway abnormalities may be a major metabolic disturbance underlying ASD that can be leveraged as biomarkers to improve symptoms and prevent ASD.